Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).

ClinicalTrials.gov ID: NCT02480153

Public ClinicalTrials.gov record NCT02480153. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 6:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3 RANDOMIZED, DOUBLE-BLIND STUDY ASSESSING THE EFFICACY AND SAFETY OF PF-06410293 AND ADALIMUMAB IN COMBINATION WITH METHOTREXATE IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE TO METHOTREXATE

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will assess the efficacy, safety, and immunogenicity of PF-06410293 and adalimumab in combination with methotrexate in subjects with moderately to severly active rheumatoid arthritis who have had an inadequate response to methotrexate. In an additional optional portion of the study, during open label Treatment Period 3 (TP3), a subset of subjects used a Prefilled Pen (PFP) to administer up to 3 injections of their study treatment (PF-06410293) at home.

Study identification

NCT ID
NCT02480153
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
597 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 24, 2015
Primary completion
Aug 30, 2016
Completion
Dec 5, 2017
Last update posted
Jan 22, 2019

2015 – 2017

United States locations

U.S. sites
49
U.S. states
23
U.S. cities
46
Facility City State ZIP Site status
ArthroCare, Arthritis Care & Research P.C. Gilbert Arizona 85234
Arizona Arthritis & Rheumatology Associates, PC Glendale Arizona 85306
Arizona Arthritis & Rheumatology Associates, PC Phoenix Arizona 85032
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare Fullerton California 92835
East Bay Rheumatology Medical Group, Inc. San Leandro California 94578
Westlake Medical Research Thousand Oaks California 91360
Inland Rheumatology Clinical Trials, Inc. Upland California 91786
Desert Valley Medical Group Victorville California 92395
Javed Rheumatology Associates, Inc Newark Delaware 19713
Arthritis and Rheumatic Disease Specialties Aventura Florida 33180
Robert W. Levin, MD, PA Clearwater Florida 33765
International Medical Research Daytona Beach Florida 32117
SIMED Arthritis Center Gainesville Florida 32607
Southeastern Integrated Medical, PL, d/b/a Florida Medical Research Gainesville Florida 32607
Rheumatology Associates of Central Florida, P.A. Orlando Florida 32806
Sarasota Arthritis Research Center Sarasota Florida 34239
Alastair C. Kennedy, MD Vero Beach Florida 32960
Indian River Primary Care Vero Beach Florida 32960
St Luke's Intermountain Research Center Boise Idaho 83702
St Luke' s Clinic Meridian Idaho 83642
Physician's Clinic of Iowa, P.C. Cedar Rapids Iowa 52403
Graves-Gilbert Clinic Bowling Green Bowling Green Kentucky 42101
The Center for Rheumatology and Bone Research Wheaton Maryland 20902
Bronson Internal Medicine and Rheumatology Battle Creek Michigan 49015
North Mississippi Medical Clinics, Inc. - Clinical Research Tupelo Mississippi 38801
Physician Research Collaboration, LLC Lincoln Nebraska 68516
Westroads Clinical Research, Inc. Omaha Nebraska 68114
Arthritis, Rheumatic & Back Disease Associates, P.A. Voorhees Township New Jersey 08043
Manhattan Medical Research New York New York 10016
Buffalo Rheumatology and Medicine PLLC Orchard Park New York 14127
Physicians East PA Greenville North Carolina 27834
Cincinnati Rheumatic Disease Study Group, Inc. Cincinnati Ohio 45242
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Clinical Research of Reading, LLC Wyomissing Pennsylvania 19610
Low Country Rheumatology, PA Charleston South Carolina 29406
Regional Health Clinical Research Rapid City South Dakota 57701
Regional Medical Clinic - Rheumatology Rapid City South Dakota 57701
West Tennessee Research Institute Jackson Tennessee 38305
Ramesh C Gupta, M.D. Memphis Tennessee 38119
Amarillo Center for Clinical Research, Ltd. Amarillo Texas 79124
Austin Regional Clinic Austin Texas 78731
Metroplex Clinical Research Center Dallas Texas 75231
The Clinical Research Institute of Houston, LLC Houston Texas 77090
Accurate Clinical Research League City Texas 77573
Southwest Rheumatology Research, LLC Mesquite Texas 75150
Northwest Diagnostic Clinic, PA Shenandoah Texas 77380
Center for Arthritis and Rheumatic Diseases, P.C. Chesapeake Virginia 23320
Wenatchee Valley Hospitals & Clinics Wenatchee Washington 98801
Rheumatology and Pulmonary Clinic Beckley West Virginia 25801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 134 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02480153, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2019 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02480153 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →